Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Developing therapies for neurodegenerative diseases such as PD should be preceded by research on its exact pathophysiological mechanisms. As a research method to elucidate disease mechanism, gene expression profiling has recently been paid attention. The technique consists of comparing the gene expression levels between healthy populations and PD patients as the basis for inferring the pathological mechanism of PD. Although many studies have been undertaken using this technique, controlling related variables, such as gender, disease stage, and anatomical area, remains a challenge. Additionally, it is necessary to establish strategies for acquiring access to obta...
Thesis (Ph.D.)--Boston UniversityParkinson disease (PD) is the second most common neurodegenerative ...
The commonest known cause of Parkinson's disease (PD) is the G2019S mutation of the LRRK2 gene, but ...
Parkinson’s disease (PD) is the second most frequent neurogenic disease after Alzheimer’s disease. T...
Parkinson’s disease (PD) is an irreversible and incurable multigenic neurodegenerative disorder. It ...
Parkinson's disease (PD) is an irreversible and incurable multigenic neurodegenerative disorder. It ...
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, affecting ~1.8% of...
Parkinson disease (PD) progresses relentlessly and affects approximately 4% of the population aged o...
Background: A blood-based test for the early detection of Parkinson’s disease (PD) would be an impor...
<div><p>The prognosis of neurodegenerative disorders is clinically challenging due to the inexistenc...
The prognosis of neurodegenerative disorders is clinically challenging due to the inexistence of est...
Introduction: The recent studies of Parkinson’s disease (PD) indicate that genetics and environmen-t...
AbstractThe study of gene expression has undergone a transformation in the past decade as the benefi...
Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disease, affect...
Background: Parkinson’s disease (PD) is a chronic progressive neurodegenerative disorder that is cli...
Altered gene expression related to Parkinson\u27s Disease (PD) has not been described in the living ...
Thesis (Ph.D.)--Boston UniversityParkinson disease (PD) is the second most common neurodegenerative ...
The commonest known cause of Parkinson's disease (PD) is the G2019S mutation of the LRRK2 gene, but ...
Parkinson’s disease (PD) is the second most frequent neurogenic disease after Alzheimer’s disease. T...
Parkinson’s disease (PD) is an irreversible and incurable multigenic neurodegenerative disorder. It ...
Parkinson's disease (PD) is an irreversible and incurable multigenic neurodegenerative disorder. It ...
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder, affecting ~1.8% of...
Parkinson disease (PD) progresses relentlessly and affects approximately 4% of the population aged o...
Background: A blood-based test for the early detection of Parkinson’s disease (PD) would be an impor...
<div><p>The prognosis of neurodegenerative disorders is clinically challenging due to the inexistenc...
The prognosis of neurodegenerative disorders is clinically challenging due to the inexistence of est...
Introduction: The recent studies of Parkinson’s disease (PD) indicate that genetics and environmen-t...
AbstractThe study of gene expression has undergone a transformation in the past decade as the benefi...
Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disease, affect...
Background: Parkinson’s disease (PD) is a chronic progressive neurodegenerative disorder that is cli...
Altered gene expression related to Parkinson\u27s Disease (PD) has not been described in the living ...
Thesis (Ph.D.)--Boston UniversityParkinson disease (PD) is the second most common neurodegenerative ...
The commonest known cause of Parkinson's disease (PD) is the G2019S mutation of the LRRK2 gene, but ...
Parkinson’s disease (PD) is the second most frequent neurogenic disease after Alzheimer’s disease. T...